Follow-up of patients diagnosed with germinal testicular tumors (seminomas and non-seminomatous) treated with bone marrow transplant and high dose of chemotherapy Follow-up of patients diagnosed with germinal testicular tumors (seminomas and non-seminomatous) treated with bone marrow transplant and high dose of chemotherapy

Resumen

Introducción: Germinal testicular tumors are the most common malignant neoplasm in men around 20 to 34 years. Even though they are unusual, they have increased incidence in the last decade; they have an excellent prognosis and overall survival at five years, approximately 95%. Divergent data exists regarding treatment options in patients with first, second, and third relapses with conventional therapy. Some studies describe the possible benefit of using high-dose chemotherapy associated with a bone marrow transplant with variable results